Home Ingredients ElevATP®
Athletic PerformanceEnergy

ElevATP®

Evidence Level
Moderate
2 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

ElevATP® is a branded combination of ancient peat extract and apple polyphenol extract developed by FutureCeuticals as an ATP-supporting performance ingredient. Unlike products that supply ATP directly, ElevATP® is marketed to help support the body's own production of ATP within cells. Branded preclinical and acute pilot research has reported increases in whole-blood ATP after a single 150 mg serving, and short-term randomized trials in resistance-trained men have examined effects on strength, power, and body composition over 12 weeks at doses of 150 mg/day. Independent peer-reviewed evidence is limited, with most published work conducted by the ingredient's research group, but it remains one of the few sports-nutrition ingredients with branded trials targeting bioenergetic markers.

Studied Dose 150 mg/day in branded human studies, taken with or without other workout ingredients.
Active Compound Standardized proprietary blend of ancient peat extract (rich in plant-derived microelements) and apple polyphenol extract (phloridzin, catechins).

Benefits

Supports Endogenous ATP Production

ElevATP® is marketed to help support the body's own production of ATP, with branded acute studies reporting increases in whole-blood ATP after a single oral dose, suggesting a bioenergetic mechanism rather than direct ATP supplementation.

Supported by Trial 2

May Support Strength Adaptations

A 12-week resistance-training trial in trained men reported that supplementing with 150 mg/day of an ancient peat and apple extract blend was associated with greater lower-body strength gains compared with placebo over a periodized training program.

Supported by Trial 1

Helps Support Lean Body Composition

Branded 12-week work combining ElevATP® with caffeine-containing co-ingredients reported improvements in body composition markers without adverse effects on hematology, supporting a potential role in lean tissue maintenance with training.

Supported by Trial 2

Caffeine-Free Performance Option

Because ElevATP® is non-stimulant on its own, it can be stacked with stimulant or non-stimulant pre-workouts and used in evening training without contributing to caffeine intake.

Supported by Trial 2

Mechanism of action

1

Mitochondrial Bioenergetic Support

Plant-derived trace minerals from ancient peat and apple polyphenols are hypothesized to influence mitochondrial enzyme function and electron transport chain efficiency, contributing to increased ATP turnover capacity.

2

Polyphenol Antioxidant Action

Apple-derived polyphenols quench reactive oxygen species generated during exercise, potentially limiting oxidative damage that can otherwise impair mitochondrial function and recovery between bouts.

3

Improved Cellular Energy Currency

By raising the steady-state pool of ATP available within cells, the ingredient is theorized to support performance-relevant cellular work — though the link between blood ATP measurements and actual training outcomes is still being characterized.

Clinical trials

1
Ancient Peat and Apple Extract: Strength and Power

Randomized, double-blind, placebo-controlled trial; 150 mg/day ancient peat and apple extract for 12 weeks alongside periodized resistance training

Resistance-trained men

The active group showed greater lower-body strength adaptations and better-preserved power output during an intense overreach phase compared with placebo, with no adverse hematological or safety signals over 12 weeks.

2
Caffeine + ElevATP® on Body Composition

Randomized, double-blind, placebo-controlled trial; combined 150 mg ElevATP® plus extended-release caffeine blend for 12 weeks with supervised resistance training

21 resistance-trained men (~27 years)

The active group improved measures of body composition with no adverse changes in clinical hematology compared with placebo, suggesting a possible additive role of ElevATP® with caffeine-containing workout support.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated at 150 mg/day in published 12-week trials in healthy adults.
Mild GI upset is occasionally reported with peat-based extracts.
Stack formulations containing caffeine carry the usual stimulant-related cautions.
Long-term safety data beyond 12 weeks are limited.

Important Drug interactions

No specific drug-drug interactions are well documented for ElevATP® alone.
Caffeine-containing stacks may interact with stimulant medications.
Discuss with a clinician before use with cardiovascular medications if formula contains caffeine.

More Athletic Performance Ingredients

Energy
Caffeine
Caffeine, a natural stimulant found in coffee, tea, and other plants, is commonly suppleme…
Muscle & Recovery
Whey Concentrate
Whey Protein Concentrate (WPC) is a high-quality protein supplement derived from milk duri…
Energy
Iron
Iron is an essential trace mineral and a central component of hemoglobin, enabling red blo…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…

Frequently asked questions about ElevATP®

What is the recommended dosage of ElevATP®?

The clinically studied dose for ElevATP® is 150 mg/day in branded human studies, taken with or without other workout ingredients.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is ElevATP® used for?

ElevATP® is studied for supports endogenous atp production, may support strength adaptations, helps support lean body composition. ElevATP® is marketed to help support the body's own production of ATP, with branded acute studies reporting increases in whole-blood ATP after a single oral dose, suggesting a bioenergetic mechanism rather than direct ATP supplementation.

Are there side effects from taking ElevATP®?

Reported potential side effects may include: Generally well tolerated at 150 mg/day in published 12-week trials in healthy adults. Mild GI upset is occasionally reported with peat-based extracts. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does ElevATP® interact with medications?

Known drug interactions may include: No specific drug-drug interactions are well documented for ElevATP® alone. Caffeine-containing stacks may interact with stimulant medications. Consult a pharmacist or healthcare provider if you take prescription medications.

Is ElevATP® good for athletic performance?

Yes, ElevATP® is researched for Athletic Performance support. ElevATP® is marketed to help support the body's own production of ATP, with branded acute studies reporting increases in whole-blood ATP after a single oral dose, suggesting a bioenergetic mechanism rather than direct ATP supplementation.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Joy JM, Vogel RM, Moon JR, et al. Ancient peat and apple extracts supplementation may improve strength and power adaptations in resistance trained men. BMC Complement Altern Med. 2016;16:224. doi: 10.1186/s12906-016-1222-x.PubMedUsed to support: 12-week RCT of 150 mg/day ancient peat and apple extract (ElevATP) in resistance-trained men showing greater strength and preserved power adaptations vs placebo.
  2. Joy JM, Vogel RM, Moon JR, Falcone PH, Mosman MM, Kim MP. Twelve weeks supplementation with an extended-release caffeine and ATP-enhancing supplement may improve body composition without affecting hematology in resistance-trained men. J Int Soc Sports Nutr. 2016;13:25. doi: 10.1186/s12970-016-0136-9.PubMedUsed to support: 12-week RCT combining ElevATP with extended-release caffeine in 21 resistance-trained men showing improvements in body composition without adverse hematology vs placebo.
  3. Reyes-Izquierdo T, Nemzer B, Shu C, et al. The effect of elevATP on whole blood ATP levels: a single dose, crossover clinical study. J Aging Res Clin Practice. 2014;3(1):56-60.SourceUsed to support: Acute single-dose crossover pilot reporting increased whole-blood ATP after 150 mg ElevATP vs placebo (peer-reviewed journal, not PubMed indexed).